EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cuproptosis‐Related Ferroptosis Gene Signature: A Prognostic Tool for Colon Cancer Patients

Yanlin Tan iD, Jinxiu Zhang iD, Ruoxi Cheng iD, Wenfang Yang iD, Xiaoping Pan iD, Kaoyan Feng iD, Mengbin Qin iD, Jie'an Huang iD

Cancer Reports · 2025

DOI: 10.1002/cnr2.70372 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Reports, 2025. Verfasst von Yanlin Tan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China. Hauptthemen laut MEDLINE: Ferroptosis, Colonic Neoplasms, Biomarkers, Tumor, Adenocarcinoma. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Cultivation Science Foundation of The Second Affiliated Hospital of Guangxi Medical University, Guangxi Natural Science Foundation, Self-financed Scientific Research Project of the Health Commission of the Guangxi Zhuang Autonomous Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ferroptosis and cuprotosis, two distinct mechanisms of programmed cell death, play key roles in colon cancer development. This study aimed to construct a prognostic model for predicting colon adenocarcinoma (COAD) prognosis based on the differential expression of cuproptosis‐related ferroptosis genes (CFRGs). Methods and Results Transcriptomic data and clinical data of COAD patients were obtained from The Cancer Genome Atlas and Gene Expression Omnibus databases. A combination of methods, including analysis of variance, Pearson correlation analysis, Least absolute shrinkage and selection operator (LASSO) algorithm, and Cox regression was used to construct the CFRGs signatures. In addition, multiple algorithmic strategies were employed to explore the potential association between risk scores and immune infiltration features. Single‐cell datasets were used to analyze model genes. Somatic mutations and drug sensitivities were compared across risk groups. Immunohistochemical analysis was performed to verify the expression of the main characterized genes. We identified eight pivotal genes in constructing the CFRGs signature. Single‐cell RNA sequencing revealed differential expression of CFRGs in the COAD tumor microenvironment. The nomogram confirmed that risk scoring serves as an independent prognostic factor for COAD. The high‐risk group exhibited higher immune cell and stromal cell infiltration, as well as immune checkpoint expression. Patients in the high‐risk group may benefit from olanzapine administration. Both RT‐PCR and immunohistochemistry have confirmed that the expression levels of GLS and YAP1 in COAD tissues are significantly higher than those in adjacent non‐cancerous tissues.

Conclusions

The CFRGs risk prognosis model can effectively predict patients' immune infiltration and immunotherapy response, providing a new reference basis for individualized treatment plans for COAD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisColonic NeoplasmsBiomarkers, TumorAdenocarcinomaHumansPrognosisTumor MicroenvironmentGene Expression Regulation, NeoplasticNomogramsMaleTranscriptomeFemaleGene Expression ProfilingMiddle AgedSingle-Cell Analysis

Stichwörter der Autor:innen

colon cancercuproptosisferroptosisprognosistumor microenvironment landscape

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Gastroenterology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.

ORCID-Profile: Yanlin Tan, Jinxiu Zhang, Ruoxi Cheng, Wenfang Yang, Xiaoping Pan, Kaoyan Feng, Mengbin Qin, Jie'an Huang

Förderung

  • the Cultivation Science Foundation of The Second Affiliated Hospital of Guangxi Medical University
  • Guangxi Natural Science Foundation
  • Self-financed Scientific Research Project of the Health Commission of the Guangxi Zhuang Autonomous Region
  • Scientific Research Project of the Second Affiliated Hospital of Guangxi Medical University
  • Natural Science Foundation of Guangxi Zhuang Autonomous Region

Zitieren

APA

Tan, Y., Zhang, J., Cheng, R., Yang, W., Pan, X., Feng, K., Qin, M., & Huang, J. (2025). Cuproptosis‐Related Ferroptosis Gene Signature: A Prognostic Tool for Colon Cancer Patients. Cancer Reports. https://doi.org/10.1002/cnr2.70372

Vancouver

Tan Y, Zhang J, Cheng R, Yang W, Pan X, Feng K, et al. Cuproptosis‐Related Ferroptosis Gene Signature: A Prognostic Tool for Colon Cancer Patients. Cancer Reports. 2025. doi:10.1002/cnr2.70372

BibTeX
@article{Tan2025,
  author = {Tan, Yanlin and Zhang, Jinxiu and Cheng, Ruoxi and Yang, Wenfang and Pan, Xiaoping and Feng, Kaoyan and Qin, Mengbin and Huang, Jie'an},
  title = {Cuproptosis‐Related Ferroptosis Gene Signature: A Prognostic Tool for Colon Cancer Patients},
  journal = {Cancer Reports},
  year = {2025},
  doi = {10.1002/cnr2.70372}
}
Kostenlos starten →